![Leah Neufeld](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leah Neufeld
Personalreferent bei
IMMUNEERING CORPORATION
Vermögen: 147 694 $ am 31.08.2026
Profil
Leah R.
Neufeld is currently Chief People Officer at Immuneering Corp.
since 2022.
Former positions include Chief Human Resources at Luzsana Biotechnology, Inc. from 2021 to 2022, Vice President-People at Prevail Therapeutics, Inc. from 2019 to 2021, Head-Human Resources at Intercept Pharmaceuticals, Inc. from 2015 to 2019, Global Head-Human Resources at NPS Pharmaceuticals, Inc. from 2014 to 2015, Director-Human Resources at Daiichi Sankyo Pharma, Inc. from 2009 to 2014, and Manager-Human Resources at Johnson & Johnson from 2002 to 2009.
Education includes undergraduate studies at American University and graduate studies at The Johns Hopkins University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.03.2026 | 29’598 ( 0.05% ) | 147 694 $ | 31.08.2026 |
Aktive Positionen von Leah Neufeld
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNEERING CORPORATION | Personalreferent | 20.10.2022 |
Ehemalige bekannte Positionen von Leah Neufeld
| Unternehmen | Position | Ende |
|---|---|---|
Luzsana Biotechnology, Inc.
 Luzsana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Personalreferent | 01.10.2022 |
| PREVAIL THERAPEUTICS INC. | Personalreferent | 01.08.2021 |
| INTERCEPT PHARMACEUTICALS, INC. | Personalreferent | 01.09.2019 |
| NPS PHARMACEUTICALS, INC. | Personalreferent | 01.07.2015 |
Daiichi Sankyo Pharma, Inc.
 Daiichi Sankyo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Personalreferent | 01.01.2014 |
Ausbildung von Leah Neufeld
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
83
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatments of rare diseases | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
American University
 American University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuneering Corp.
 Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
Daiichi Sankyo Pharma, Inc.
Daiichi Sankyo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for neurodegenerative diseases | Health Technology |
Luzsana Biotechnology, Inc.
Luzsana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
